These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Functional Role of the Cerebellum in Parkinson Disease: A PET Study. Riou A; Houvenaghel JF; Dondaine T; Drapier S; Sauleau P; Drapier D; Duprez J; Guillery M; Le Jeune F; Verin M; Robert G Neurology; 2021 Jun; 96(23):e2874-e2884. PubMed ID: 33910940 [TBL] [Abstract][Full Text] [Related]
23. Network modulation in the treatment of Parkinson's disease. Asanuma K; Tang C; Ma Y; Dhawan V; Mattis P; Edwards C; Kaplitt MG; Feigin A; Eidelberg D Brain; 2006 Oct; 129(Pt 10):2667-78. PubMed ID: 16844713 [TBL] [Abstract][Full Text] [Related]
24. FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease. Matthews DC; Lerman H; Lukic A; Andrews RD; Mirelman A; Wernick MN; Giladi N; Strother SC; Evans KC; Cedarbaum JM; Even-Sapir E Neuroimage Clin; 2018; 20():572-579. PubMed ID: 30186761 [TBL] [Abstract][Full Text] [Related]
25. Metabolic correlates of levodopa response in Parkinson's disease. Feigin A; Fukuda M; Dhawan V; Przedborski S; Jackson-Lewis V; Mentis MJ; Moeller JR; Eidelberg D Neurology; 2001 Dec; 57(11):2083-8. PubMed ID: 11739830 [TBL] [Abstract][Full Text] [Related]
26. A disease-specific metabolic brain network associated with corticobasal degeneration. Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922 [TBL] [Abstract][Full Text] [Related]
30. Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. Tang CC; Poston KL; Dhawan V; Eidelberg D J Neurosci; 2010 Jan; 30(3):1049-56. PubMed ID: 20089913 [TBL] [Abstract][Full Text] [Related]
31. Stereotyped Relationship Between Motor and Cognitive Metabolic Networks in Parkinson's Disease. Rus T; Schindlbeck KA; Tang CC; Vo A; Dhawan V; Trošt M; Eidelberg D Mov Disord; 2022 Nov; 37(11):2247-2256. PubMed ID: 36054380 [TBL] [Abstract][Full Text] [Related]
32. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: a PET study of resting-state glucose metabolism. Fukuda M; Mentis MJ; Ma Y; Dhawan V; Antonini A; Lang AE; Lozano AM; Hammerstad J; Lyons K; Koller WC; Moeller JR; Eidelberg D Brain; 2001 Aug; 124(Pt 8):1601-9. PubMed ID: 11459751 [TBL] [Abstract][Full Text] [Related]
33. Network correlates of disease severity in multiple system atrophy. Poston KL; Tang CC; Eckert T; Dhawan V; Frucht S; Vonsattel JP; Fahn S; Eidelberg D Neurology; 2012 Apr; 78(16):1237-44. PubMed ID: 22491861 [TBL] [Abstract][Full Text] [Related]
34. Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease. Kaasinen V; Maguire RP; Hundemer HP; Leenders KL J Neurol; 2006 Mar; 253(3):340-8. PubMed ID: 16222426 [TBL] [Abstract][Full Text] [Related]
35. Cerebral glucose metabolic features of Parkinson disease and incident dementia: longitudinal study. Bohnen NI; Koeppe RA; Minoshima S; Giordani B; Albin RL; Frey KA; Kuhl DE J Nucl Med; 2011 Jun; 52(6):848-55. PubMed ID: 21571793 [TBL] [Abstract][Full Text] [Related]
36. Divergent expression of regional metabolic topographies in Parkinson's disease and normal ageing. Moeller JR; Eidelberg D Brain; 1997 Dec; 120 ( Pt 12)():2197-206. PubMed ID: 9448575 [TBL] [Abstract][Full Text] [Related]
37. Consistent Abnormalities in Metabolic Patterns of Lewy Body Dementias. Lu J; Ge J; Chen K; Sun Y; Liu F; Yu H; Xu Q; Li L; Ju Z; Lin H; Guan Y; Guo Q; Wang J; Zuo C; Wu P Mov Disord; 2022 Sep; 37(9):1861-1871. PubMed ID: 35857319 [TBL] [Abstract][Full Text] [Related]
38. Modified Fluorodeoxyglucose Metabolism in Motor Circuitry by Subthalamic Deep Brain Stimulation. Cao C; Zhang H; Li D; Zhan S; Zhang J; Zhang X; Zuo C; Sun B Stereotact Funct Neurosurg; 2017; 95(2):93-101. PubMed ID: 28259880 [TBL] [Abstract][Full Text] [Related]
39. Occipital hypometabolism is a risk factor for conversion to Parkinson's disease in isolated REM sleep behaviour disorder. Carli G; Meles SK; Janzen A; Sittig E; Kogan RV; Perani D; Oertel WH; Leenders KL; Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3290-3301. PubMed ID: 37310428 [TBL] [Abstract][Full Text] [Related]
40. Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson's disease. Borghammer P; Cumming P; Aanerud J; Gjedde A Neuroimage; 2009 Apr; 45(2):249-57. PubMed ID: 18718541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]